TickerFactsScreenerDevelopers

Kalaris Therapeutics, Inc. (KLRS) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2019: $339.0K2020: $235.0K2021: $26.0K2025: $200.0K$200.0K
2019Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$200.0K—
2021$26.0K-88.9%
2020$235.0K-30.7%
2019$339.0K—